UK-4 - 715104450-Complusory Drug Testing Quality Assurance

The Ministry of Defence has initiated an active tender for the provision of Quality Assurance support to the Armed Forces Compulsory Drug Testing (CDT) programme, with a focus on services related to analysis and laboratory IT infrastructure. This procurement is being conducted as an open procedure, inviting tenders from interested parties until 11th February 2026. The procurement addresses industry categories such as analysis services and laboratory services, and the services will be delivered within the United Kingdom.

The contract period is set from 1st April 2026 through 31st March 2028, with options for additional one-year extensions. The estimated gross value of the contract is £228,000, and successful proposals will need to adhere to submission requirements via electronic means, as detailed in the procurement documents. This tender presents significant growth opportunities for businesses, particularly those specialising in quality control, laboratory testing, and related technical support services.

Companies providing innovative solutions in blind performance testing, on-site inspections, and audit trails will find this procurement well-aligned with their capabilities. Additionally, businesses experienced in integrating IT infrastructure for laboratory services should consider submitting proposals. The Ministry of Defence's complex requirements are well-suited for SMEs and organisations leveraging technical and managerial expertise, allowing these entities to expand their footprint within the public sector, enhance their service offerings, and foster long-term partnerships with a central government department.